CAJ | 학술논문

目的：观察平艾合剂玉号方治疗艾滋病的疗效。方法：将107例患者分为单服平艾合剂玉号方（太芪培元颗粒）组与平艾合剂玉号方合用西药（齐多夫定300 mg、拉米夫定150 mg、奈韦拉平200 mg，每日两次）组，即中医组与中西医组。结果：经6个月治疗后，中医组患者中医证候积分、卡洛夫斯基积分、CD4+ T淋巴细胞计数改善程度较中西医组明显，且差异有统计学意义。结论：平艾合剂玉号方有改善艾滋病患者症状，提高免疫力和生存质量的作用。
목적：관찰평애합제옥호방치료애자병적료효。방법：장107례환자분위단복평애합제옥호방（태기배원과립）조여평애합제옥호방합용서약（제다부정300 mg、랍미부정150 mg、내위랍평200 mg，매일량차）조，즉중의조여중서의조。결과：경6개월치료후，중의조환자중의증후적분、잡락부사기적분、CD4+ T림파세포계수개선정도교중서의조명현，차차이유통계학의의。결론：평애합제옥호방유개선애자병환자증상，제고면역력화생존질량적작용。
This study was aimed to observe the clinical effect of Ping-Ai GranulesⅠin the treatment of HIV/AIDS . A total of 107 AIDS cases were divided into Ping-Ai GranulesⅠgroup and Ping-Ai GranulesⅠunited with HAART group. The results showed that there was significant difference between Ping-Ai GranulesⅠgroup and Ping-Ai GranulesⅠunited with HAART group in aspects of symptoms, physical signs, Karnovsky Score and changes of CD4+ T lymphocyte . It was concluded that Ping-Ai GranulesⅠhad the function of improving patient's symptom and increasing patient's immunity and living quality .